帕洛瓦罗在纤维发育不良性骨渐进症中的作用:综述和前景
相关实验视频
Updated: Jun 1, 2025

12:03
Fertility Preservation in Patients with Severe Ovarian Dysfunction
Published on: March 25, 2021
4.5K
Vincent A Verheij1, Robert J Diecidue2, Esmée Botman1
1Department of Internal Medicine, Section Endocrinology and Metabolism - Rare Bone Disease Center, Amsterdam University Medical Center (Amsterdam UMC), location VU University Medical Center (VUMC), Amsterdam, Netherlands.
Expert opinion on pharmacotherapy
|January 21, 2025
概括
帕洛瓦罗是一种视网膜酸受体马激动剂,是某些地区首个批准用于治疗骨髓纤维发育不良进展症 (FOP) 的药物. 尽管在抑制新异种类骨化方面具有适度的好处,但人们仍然担心其使用和长期影响.
科学领域:
- 药理学 药理学是指药理学的学科.
- 罕见疾病 罕见疾病
- 临床试验 临床试验
背景情况:
- 纤维发育性骨渐进性 (FOP) 是一种罕见的遗传疾病,其特征是渐进性的异型骨化 (HO).
- 帕洛瓦罗是一种视网膜酸受体马激动剂,已被研究为一种潜在的治疗方法,以抑制FOP患者的新HO形成.
研究的目的:
- 审查发育史和临床试验数据 palovarotene 的 FOP.
- 讨论关于帕洛瓦罗的有效性和安全性的监管批准过程和专家意见.
主要方法:
- 在FOP中对palovarotene进行第二期和第三期临床试验的审查.
- 对有关抑制新HO形成的后期数据的分析.
- 全球FOP专家就临床和监管方面进行讨论.
主要成果:
- 帕洛瓦罗已在美国,加拿大和澳大利亚获得监管批准,作为第一个FOP治疗.
- 后期分析表明,帕洛瓦罗在抑制新的HO形成方面具有潜在的适度益处.
- 关于帕洛瓦罗的普遍使用和长期风险的担忧和局限性仍然存在.
结论:
- 帕洛瓦罗的区域批准对FOP社区来说是一个重要的里程碑.
- 需要进一步的研究才能充分了解帕洛瓦罗治疗的长期风险和益处.
- 由于持续存在的担忧,该药物在欧洲获得市场许可的途径仍在考虑中.
相关概念视频
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
Fractures: Bone Repair
2.9K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
2.9K
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
Bone Remodeling
38.1K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.1K
Pulmonary Hypertension: Classification and Pathogenesis
149
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
149

